1 01/07/2025 30/06/2026 2026-06-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2025-07-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 14972877 2025-07-01 2026-06-30 14972877 2026-06-30 14972877 2025-06-30 14972877 2024-07-01 2025-06-30 14972877 2025-06-30 14972877 2024-06-30 14972877 bus:RegisteredOffice 2025-07-01 2026-06-30 14972877 bus:LeadAgentIfApplicable 2025-07-01 2026-06-30 14972877 bus:Director1 2025-07-01 2026-06-30 14972877 core:WithinOneYear 2026-06-30 14972877 core:WithinOneYear 2025-06-30 14972877 bus:Micro-entities 2025-07-01 2026-06-30 14972877 bus:AuditExemptWithAccountantsReport 2025-07-01 2026-06-30 14972877 bus:SmallCompaniesRegimeForAccounts 2025-07-01 2026-06-30 14972877 bus:PrivateLimitedCompanyLtd 2025-07-01 2026-06-30 14972877 bus:FullAccounts 2025-07-01 2026-06-30
Company registration number: 14972877
ASJ PHARMA LIMITED
Unaudited filleted financial statements
30 June 2026
ASJ PHARMA LIMITED
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
ASJ PHARMA LIMITED
Directors and other information
Director Mr Aarondeep Singh Johal
Company number 14972877
Registered office 3 Alloa Road
Goodmayes
Ilford
England
IG3 9SW
Business address 3 Alloa Road
Goodmayes
Ilford
England
IG3 9SW
Accountants Xeinadin London Limited (Ilford)
19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD
ASJ PHARMA LIMITED
Chartered accountants report to the director on the preparation of the
unaudited statutory financial statements of ASJ PHARMA LIMITED
Year ended 30 June 2026
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of ASJ PHARMA LIMITED for the year ended 30 June 2026 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the director of ASJ PHARMA LIMITED, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of ASJ PHARMA LIMITED and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ASJ PHARMA LIMITED and its director as a body for our work or for this report.
It is your duty to ensure that ASJ PHARMA LIMITED has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of ASJ PHARMA LIMITED. You consider that ASJ PHARMA LIMITED is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of ASJ PHARMA LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Xeinadin London Limited (Ilford)
19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD
31 August 2026
ASJ PHARMA LIMITED
Statement of financial position
30 June 2026
2026 2025
£ £
Fixed assets 5,394 6,743
_______ _______
Current assets 64,653 50,848
Creditors: amounts falling due within one year ( 63,209) ( 47,577)
_______ _______
Net current assets 1,444 3,271
_______ _______
Total assets less current liabilities 6,838 10,014
Accruals and deferred income ( 1,560) ( 1,560)
_______ _______
Net assets 5,278 8,454
_______ _______
Capital and reserves 5,278 8,454
_______ _______
ASJ PHARMA LIMITED
Year ended 30 June 2026
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
2. Directors advances, credits and guarantees
There were no advances as at the period ended 30 June 2026.
For the year ending 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 31 August 2026 , and are signed on behalf of the board by:
Mr Aarondeep Singh Johal
Director
Company registration number: 14972877
The company is a private company limited by shares, registered in England.